CP
VRTX icon

Corbenic Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Corbenic Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-58
Closed -$14K – 259
2020
Q4 		$14K Hold
58
– – 0.01% 114
2020
Q3 		$16K Sell
58
-11
-16% -$3.04K 0.01% 96
2020
Q2 		$20K Hold
69
– – 0.01% 86
2020
Q1 		$16K Hold
69
– – 0.01% 89
2019
Q4 		$15K Buy
+69
New +$14K 0.01% 111
2017
Q4 		– Sell
-78
Closed -$12K – 248
2017
Q3 		$12K Buy
+78
New +$11.7K 0.02% 138
2017
Q1 		– Sell
-24
Closed -$2K – 218
2016
Q4 		$2K Hold
24
– – ﹤0.01% 185
2016
Q3 		$2K Buy
+24
New +$2.27K ﹤0.01% 183
2015
Q1 		– Sell
-38
Closed -$5K – 216
2014
Q4 		$5K Buy
+38
New +$4.28K ﹤0.01% 163

Other funds holding VRTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return